Search Results - Michej, W

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Validation of the Joensuu risk criteria for primary resectable gastrointestinal stromal tumour – The impact of tumour rupture on patient outcomes

    Validation of the Joensuu risk criteria for primary resectable gastrointestinal stromal tumour – The impact of tumour rupture on patient outcomes by Rutkowski, P, Bylina, E, Wozniak, A, Nowecki, Z.I, Osuch, C, Matlok, M, Świtaj, T, Michej, W, Wroński, M, Głuszek, S, Kroc, J, Nasierowska-Guttmejer, A, Joensuu, H

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Treatment of advanced dermatofibrosarcoma protuberans with imatinib mesylate with or without surgical resection

    Treatment of advanced dermatofibrosarcoma protuberans with imatinib mesylate with or without surgical resection by Rutkowski, P, Dębiec-Rychter, M, Nowecki, ZI, Michej, W, Symonides, M, Ptaszynski, K, Ruka, W

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    The analysis of the outcomes and factors related to iliac–obturator involvement in cutaneous melanoma patients after lymph node dissection due to positive sentinel lymph node biopsy or clinically detected inguinal metastases

    The analysis of the outcomes and factors related to iliac–obturator involvement in cutaneous melanoma patients after lymph node dissection due to positive sentinel lymph node biops... by Zdzienicki, M, Rutkowski, P, Nowecki, Z.I, van Akkooi, A.C.J, Michej, W, Dziewirski, W, Świtaj, T, Pieńkowski, A, Sałamacha, M, Bylina, E, Eggermont, A.M.M

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Surgical resection of residual disease in initially inoperable imatinib-resistant/intolerant gastrointestinal stromal tumor treated with sunitinib

    Surgical resection of residual disease in initially inoperable imatinib-resistant/intolerant gastrointestinal stromal tumor treated with sunitinib by Ruka, W, Rutkowski, P, Szawłowski, A, Nowecki, Z, Dębiec-Rychter, M, Grzesiakowska, U, Dziewirski, W, Siedlecki, J.A, Michej, W

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    9405 Spectrum of KIT and PDGFRA mutations in primary gastrointestinal stromal tumours: Polish clinical GIST registry experience

    9405 Spectrum of KIT and PDGFRA mutations in primary gastrointestinal stromal tumours: Polish clinical GIST registry experience by Wozniak, A, Rutkowski, P, Debiec-Rychter, M, Siedlecki, J, Michej, W, Osuch, C, Matlok, M, Ruka, W, Limon, J

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    7006 ORAL Prognosis depends on micro-anatomic patterns of melanoma micrometastases within the sentinel node (SN). A multicenter study in 388 SN positive patients

    7006 ORAL Prognosis depends on micro-anatomic patterns of melanoma micrometastases within the sentinel node (SN). A multicenter study in 388 SN positive patients by van Akkooi, A.C.J, Nowecki, Z.I, Voit, C, Schaefer, G, Michej, W, Kliffen, M, Schmitz, P.I.M, Ruka, W, Eggermont, A.M.M

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: